Negative Pressure Wound Therapy Market

Negative Pressure Wound Therapy Market Outlook from (2023 to 2033)

The Negative Pressure Wound Therapy Market is estimated to be valued at USD 6.5 billion in 2023. The market is expected to reach USD 10.8 billion by 2033, developing at a CAGR of 5.3%.

Negative Pressure Wound Therapy Market Trend Analysis

• Rising prevalence of chronic wounds such as diabetic foot ulcers, post-surgical ulcers, and pressure ulcers, and increasing wound care spending, drive the demand for negative pressure wound therapy.
• The growing adoption of negative pressure wound therapy devices in homecare settings to minimize the risk of infections and reduce healthcare costs will further push the demand for negative pressure wound therapy during the forthcoming years.

Attributes	Key Insights
Negative Pressure Wound Therapy Market Estimated Size in 2023	USD 6.5 billion
Projected Market Value in 2033	USD 10.8 billion
Value-based CAGR from 2023 to 2033	5.3%

2018 to 2022 Historical Analysis vs. 2023 to 2033 Market Forecast Projections

A study by our analysts found that a 3.5% CAGR was experienced between 2018 and 2022 in the driveline additive market. Global demand for negative pressure wound therapy is predicted to increase at a CAGR of 5.3% from 2023 to 2033.

Growth in the negative pressure wound therapy market is driven by the rising prevalence of chronic wounds worldwide, growing awareness about the benefits of NPWT, increasing need for better wound care to reduce mortality rate, and continuous NPWT product launches.

Negative wound pressure therapy is a non-invasive technique that uses sub-atmospheric pressure to aid in the management of chronic and acute open wounds. It has become one of the most effective treatments for the management of chronic wounds.

The increasing incidence of chronic wounds such as diabetic foot ulcers, pressure ulcers, and post-surgical wounds is a major impetus to negative pressure wound therapy growth.

According to the International Diabetes Federation (IDF), diabetic foot and lower limb complications affect around 40 to 60 million people with diabetes globally. This rise in the number of diabetic foot ulcers will continue to create opportunities for negative pressure wound therapy device manufacturers.

Various key players are offering NPWT devices for rent to make them more accessible and affordable for patients to manage their wound healing. This will further expand the global negative pressure wound therapy market size in the future.

Historical CAGR from 2018 to 2022	3.5%
Forecast CAGR from 2023 to 2033	5.3%

Negative Pressure Wound Therapy Market Drivers

• The rising prevalence of chronic wounds, such as diabetic ulcers, pressure ulcers, and venous leg ulcers, is a significant driver for the negative pressure wound therapy market.
• The growing global aging population is expanding, increasing chronic diseases and age-related health issues. Elderly individuals are more susceptible to chronic wounds, driving the demand for an effective treatment option.
• The rapid growth of wound care clinics and specialized wound care centers has driven the demand for the negative pressure wound therapy market.
• The growing preference for cost-effective wound treatment using NPWT devices, such as portable NPWT devices and single-use NPWT devices in developing nations, drives the market demand.
• The growing demand for negative pressure wound therapy for specialized patient populations, including neonates, burn patients, and individuals with complex surgical wounds, traumatic injuries, or ostomies.
• Advancement in negative pressure wound therapy technology is expected to impact the negative pressure wound therapy market positively.

Negative Pressure Wound Therapy Market Restraints

• The upfront cost of purchasing or leasing negative pressure wound therapy equipment can be a significant barrier, especially for smaller clinics or healthcare systems.
• Access to negative pressure wound therapy devices and skilled healthcare personnel may be limited, hindering the adoption of NPWT as a treatment option.
• Healthcare providers need to invest time and resources in training their staff to ensure safe and effective negative pressure wound therapy application. Lack of training can lead to complications and suboptimal outcomes.

Country-Wise Insights

The table below showcases revenues in the top 5 leading countries, spearheaded by the United States and the United Kingdom. Through 2033, these two countries are likely to dominate the market, with a combined size of USD 8.6 billion and USD 8.2 billion.

Expected Market Values in 2033

Germany	USD 7.4 billion
India	USD 5.5 billion
The United States	USD 8.6 billion
China	USD 6.9 billion
The United Kingdom	USD 8.2 billion

Forecast CAGRs from 2023 to 2033

Germany	5.0%
India	4.8%
The United States	5.2%
China	4.9%
The United Kingdom	5.1%

Rising Prevalence of Pressure Ulcers Driving Growth in the United States

Total sales of negative pressure wound therapy in the United States accounted for 86.9% of the North American market share in 2021 and are likely to grow at a steady pace during pace. Growth in the United States negative pressure wound therapy market is driven by the rising prevalence of diabetic and pressure ulcers, the highly developed healthcare industry, increasing expenditure on wound care, and the presence of leading NPWT device manufacturers.

Over the years, there has been a sharp rise in the cases of pressure ulcers across the United States. According to the Agency for Healthcare Research and Quality (AHRQ), more than 2.5 million people in the United States develop pressure ulcers each year.

As these pressure ulcers have high morbidity and mortality rates, people with these ulcers often opt for treatments like negative pressure treatment therapy. The rise in cases of pressure ulcers will, therefore continue to boost the growth of the negative pressure wound therapy market during the forecast period.

Growing Advances in Healthcare Boost Market Demand in the United Kingdom

The United Kingdom will account for 35.7% of the negative pressure wound therapy market 2033. In 2033, the market is expected to grow by 5.1% year-on-year, reaching a valuation of USD 8.2 billion by the end of 2033.

The growing popularity of home healthcare, expansion of the advanced wound dressing market, and increasing usage of digital wound measurement devices will positively impact the negative pressure wound therapy devices market outlook in the United Kingdom.

Increasing Influx of Medical Tourists Creating Space Market Growth in Germany

With the rising incidence of chronic wounds, flourishing medical tourism industry, increasing usage of NPWT dressings, and presence of advanced healthcare facilities, Germany's negative pressure wound therapy market is poised to exhibit strong growth during the forecast period. In 2023, Germany accounted for a share of 30.2% of the European negative pressure wound therapy (NPWT) market, and this number is expected to grow substantially during the forecast period.

The rising incidence of chronic wounds and increasing spending on wound care is a major factor driving the growth of the German negative pressure wound therapy market. According to a report published in the Journal of the European Wound Management Association (EWMA Journal), around 0.24% of the population in Germany is affected by chronic wounds.

Increasing adoption of wound debridement products, advancement in wound irrigation devices, and rapid growth of the negative pressure wound therapy devices market will create opportunities for the leading NPWT players in the country.

Rising Incidence of Diabetic Foot Ulcers in China Boosting Sales of Negative Pressure Wound Devices

In 2021, China accounted for 56.0% of the East Asia negative pressure wound therapy market. Factors such as the increasing incidence of various chronic wounds like diabetic foot ulcers and pressure ulcers, and the availability of advanced NPWT devices at lower costs drive the market demand in China

Increasing government investments in expanding the healthcare industry and growing wound care spending are some of the factors driving growth in the China NPWT market.

Category-wise Insights

According to market forecasts, the standalone NPWT devices segment is predicted to dominate until 2033, with a market share of 35.5%. The post-surgical ulcers & open wound segment is expected to have a share of 30.2.

Category	Market share
Standalone NPWT Devices	35.5%
post-surgical ulcers & open wound	30.2%

Demand for Standalone NPWT Devices to Remain High in the Global Negative Pressure Wound Therapy Market

The global negative pressure wound therapy market is segmented based on product type into standalone NPWT devices, portable NPWT devices, single-use NPWT devices, NPWT dressings, and NPWT accessories. The standalone NPWT device segment sales accounted for the highest share of 35.5% in 2023 and are likely to grow further at 5.1% CAGR during the forecast period.

The growth of the segment is attributed to the rapid rise in the number of hospitals worldwide and the growing adoption of standalone NPWT devices across hospitals and ambulatory surgical centers due to high patient footfall.

The global negative pressure wound therapy market forecasts the single-use BPWT devices segment to grow considerably due to the growing health awareness among people and the rapid expansion of the disposable negative pressure wound therapy devices market across developed and developing regions.

Single-use negative pressure wound therapy devices have become a safe and effective alternative to traditional negative pressure wound therapy devices as they promote the healing of selected open wounds and reduce complication rates in closed surgical incisions.

Post-Surgical Ulcers & Open Wound Segment Creating Maximum Growth Opportunities for NPWT Device Manufacturers

According to Future Market Insights, the post-surgical ulcers & open wound segment will continue to dominate the global negative pressure wound therapy market, accounting for the largest share of 30.2% in 2023. The rising incidence of postoperative ulcers and wounds worldwide is driving this segmental growth.

Competitive Landscape

Leading negative pressure wound therapy device manufacturers are increasingly focusing on expanding their product offerings to strengthen their customer base.

Moreover, they are adopting growth strategies such as new product launches, partnerships, acquisitions, mergers, collaborations, etc. to expand their global footprint and gain a competitive edge in the global negative pressure wound therapy market. For instance,

• In March 2020, Smith+Nephew, the global medical technology business, announced the USA launch of the PICO 14 single-use negative pressure wound therapy system for use on high-risk surgical patients.
• In April 2021, Joerns Healthcare, a leading wound solutions provider, announced a nationwide partnership with Medela to expand access to innovative negative pressure wound therapy. Under this agreement, Joerns will expand its wound care portfolio to include the full Medela line of negative pressure wound therapy products, including the Invia Liberty and Invia Motion 60 NPWT Systems.

Report Scope

Attributes	Details
Estimated Market Size in 2023	USD6.5 billion
Projected Market Valuation in 2033	USD 10.8 billion
Value-based CAGR 2023 to 2033	5.3%
Forecast Period	2023 to 2033
Historical Data Available for	2018 to 2022
Market Analysis	Value in USD billion
Key Regions Covered	North America; Latin America; Western Europe; Eastern Europe; South Asia and Pacific; East Asia; Middle East and Africa
Key Market Segments Covered	Product Type, Indication, End User, Region
Key Countries Profiled	The United States, Canada, Brazil, Mexico, Germany, The United Kingdom, France, Spain, Italy, Russia, Poland, Czech Republic, Romania, India, Bangladesh, Australia, New Zealand, China, Japan, South Korea, GCC countries, South Africa, Israel
Key Companies Profiled	Cardinal Health; Mölnlycke Health Care; Acelity L.P. Inc. (3M); Lohmann & Rauscher GmbH & Co. KG; Smith & Nephew; ConvaTec Inc.; DeRoyal Industries, Inc.; HARTMANN, Medela LLC; Haromed Bvba (Belgium); Carilex Medical GmbH.; Genadyne Biotechnologies, Inc.; Cork Medical, LLC; Alleva Medical Ltd. (Devon Medical Products; Argentum Medical, LLC

Negative Pressure Wound Therapy Market by Category

By Product Type:

• Standalone NPWT Devices
  • Direct Sales
  • Rental Sales
  • Product
  • Services
• Portable NPWT Devices
  • Direct Sales
  • Rental Sales
  • Product
  • Services
  • Single-Use NPWT Devices
  • Direct Sales
  • Rental Sales
  • Product
  • Services
  • NPWT Dressings
  • Foam Dressings
  • Hydrocolloid Dressings
  • Standard Gauze Dressings
  • NPWT Accessories

By Indication:

• Diabetic Foot Ulcers
• Pressure Ulcers
• Venous Leg Ulcers
• Post-Surgical Ulcers & Open Wound
• Burn Wounds
• Other Wounds

By End-User:

• Hospitals
• Acute Care Centers
• Community Hospitals
• Ambulatory Surgical Centers
• Trauma Care Centers
• Specialty Clinics
• Home Care Settings
• Long-Term Care Centers
• Skilled Nursing Facilities

By Region:

• North America
• Latin America
• Western Europe
• Eastern Europe
• South Asia and Pacific
• East Asia
• Middle East and Africa
• Middle East and Africa

Frequently Asked Questions

What was the market value for the negative pressure wound therapy market in 2023?

As of 2023, the market for negative pressure wound therapy is expected to be valued at USD 6.5 billion.

According to FMI, what is the anticipated market value for negative pressure wound therapy in 2033?

By 2033, the market value of negative pressure wound therapy is expected to reach USD 10.8 billion.

What is the projected forecast CAGR for the negative pressure wound therapy market from 2023 to 2033?

From 2023 to 2033, negative pressure wound therapy sales are expected to flourish at a CAGR of 5.3%

Which segment is dominant in the negative pressure wound therapy market?

The standalone NPWT devices segment will account for a market share of 35.5% in 2023.

Which country is likely to be at the pinnacle of the market?

The United States is likely the top-performing market and is expected to account for a share of 86.9% by 2033.